by Pill Pals | Oct 29, 2024 | News
Delivery Method: VIA UPS Reference #: 320-25-06 Product: Drugs Recipient: Recipient Name Mr. Sudhir Shah Recipient Title President Choice All Natural, Inc. dba Om Botanical 1019 Classic RoadApex, NC 27539-4402United States Issuing Office: Center for Drug Evaluation...
by Pill Pals | Oct 29, 2024 | News
October 29, 2024 The U.S. Food and Drug Administration (FDA) is issuing this update to inform the health care community of a change in recommendations for the GE HealthCare EVair Compressor. Previously, on December 29, 2023, GE HealthCare issued an Urgent Medical...
by Pill Pals | Oct 29, 2024 | News
COMMITTEE’S OFFICIAL DESIGNATIONCellular, Tissue, and Gene Therapies Advisory Committee AUTHORITYThe Cellular, Tissue, and Gene Therapies Advisory Committee (the Committee) is established under 15 U.S.C. 1451 et seq.; 21 U.S.C. 321, 341, 342, 343, 343-1, 344, 345,...
by Pill Pals | Oct 29, 2024 | News
On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). Full prescribing...
by Pill Pals | Oct 29, 2024 | News
This recall involves updating recall instructions for using these devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue...